Cargando…
Post-translational modifications of EZH2 in cancer
Enhancer of zeste homolog 2 (EZH2), as a main component of Polycomb Repressive Complex 2, catalyzes histone H3K27me3 to silence its target gene expression. EZH2 upregulation results in cancer development and poor prognosis of cancer patients. Post-translational modifications (PTMs) are important bio...
Autores principales: | Li, Zhongwei, Li, Minle, Wang, Diandian, Hou, Pingfu, Chen, Xintian, Chu, Sufang, Chai, Dafei, Zheng, Junnian, Bai, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731458/ https://www.ncbi.nlm.nih.gov/pubmed/33308321 http://dx.doi.org/10.1186/s13578-020-00505-0 |
Ejemplares similares
-
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
por: Li, Zhongwei, et al.
Publicado: (2021) -
The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment
por: Chen, Xintian, et al.
Publicado: (2022) -
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
por: Hou, Pingfu, et al.
Publicado: (2021) -
Correction to: LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
por: Hou, Pingfu, et al.
Publicado: (2021) -
Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas
por: Wang, Yan, et al.
Publicado: (2022)